Results

Total Results: 1,684 records

Showing results for "prostate cancer screening".
Users also searched for: psa

101. Prostate Cancer Risk Assessment, Multigene Panels | Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/evidence-based-reports/er209-abstract.html
     July 01, 2012 - Prostate Cancer Risk Assessment, Multigene Panels This report addresses the evidence on … cancer. … and full text screening. … All had poor discriminative ability for predicting risk of prostate cancer and/or distinguishing between … Download Report Multigene Panels in Prostate Cancer Risk Assessment.

102. U.S. Preventive Services Task Force Issues Final Recommendation Statement for Screening for Prostate Cancer | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/us-preventive-services-task-force-issues-final-recommendation-statement-screening-prostate-cancer
     May 12, 2012 - Preventive Services Task Force Issues Final Recommendation Statement for Screening for Prostate Cancer … Preventive Services Task Force released its prostate cancer screening final recommendation statement. … final recommendation statement and the supporting evidence reports, click here /uspstf/recommendation/prostate-cancer-screening

103. Therapies for Clinically Localized Prostate Cancer: Update of a 2008 Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies-update/research
     December 01, 2019 - Therapies for Clinically Localized Prostate Cancer: Update of a … Trial (PIVOT) compared radical prostatectomy (RP) and watchful waiting (WW) in localized prostate cancer … While the SPCG-4 study found that RP reduced prostate cancer–specific mortality at 12 and 15 years, the … Six nonrandomized comparison studies reported that all-cause and prostate cancer–specific mortality was … https://effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies-update/research

104. Blood-based Tests for Multiple Cancer Screening: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-protocol.pdf
     June 05, 2024 - neoplasms"[title] OR "prostatic neoplasms"[title] OR sarcomas[title] OR "stomach neoplasms"[title] … cancer"[title] OR "prostatic cancer"[title] OR "stomach cancer"[title] OR ("tubo-ovarian"[tiab] AND … neoplasms"[title] OR "prostatic neoplasms"[title] OR sarcomas[title] OR "stomach neoplasms"[title] … cancer"[title] OR "prostatic cancer"[title] OR "stomach cancer"[title] OR ("tubo-ovarian"[tiab] AND … cancer"[title] OR "prostatic cancer"[title] OR "stomach cancer"[title] OR ("tubo-ovarian"[tiab] AND

105. Blood-based Tests for Multiple Cancer Screening: A Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cell-free-dna-protocol.pdf
     June 05, 2024 - neoplasms"[title] OR "prostatic neoplasms"[title] OR sarcomas[title] OR "stomach neoplasms"[title] … cancer"[title] OR "prostatic cancer"[title] OR "stomach cancer"[title] OR ("tubo-ovarian"[tiab] AND … neoplasms"[title] OR "prostatic neoplasms"[title] OR sarcomas[title] OR "stomach neoplasms"[title] … cancer"[title] OR "prostatic cancer"[title] OR "stomach cancer"[title] OR ("tubo-ovarian"[tiab] AND … cancer"[title] OR "prostatic cancer"[title] OR "stomach cancer"[title] OR ("tubo-ovarian"[tiab] AND

106. Therapies for Clinically Localized Prostate Cancer: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-summary.pdf
     September 01, 2020 - Therapies for Clinically Localized Prostate Cancer: Evidence Summary Comparative Effectiveness Review … Number 230 Therapies for Clinically Localized Prostate Cancer Evidence Summary Main Points … Prostate cancer mortality is infrequent in low-risk disease, and all-cause or prostate cancer mortality … Prostate cancer mortality and metastases were rare in all three groups. … Clinically Localized Prostate Cancer Evidence Report ECRI Institute,.

107. Therapies for Clinically Localized Prostate Cancer: Evidence Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/prostate-cancer-therapies-summary.pdf
     September 01, 2020 - Therapies for Clinically Localized Prostate Cancer: Evidence Summary Comparative Effectiveness Review … Number 230 Therapies for Clinically Localized Prostate Cancer Evidence Summary Main Points … Prostate cancer mortality is infrequent in low-risk disease, and all-cause or prostate cancer mortality … Prostate cancer mortality and metastases were rare in all three groups. … Clinically Localized Prostate Cancer Evidence Report ECRI Institute,.

108. 04-E029-1 Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
     December 01, 2011 - screening. … Indeed, more than half of prostate cancers detected by PSA screening are expected to be early-stage, … of the Prostate Strategic Urologic Research Endeavor). … of the Prostate Urologic Research Endeavor (CaPSURE) database, 5 the National Cancer Database (NCDB) … Similarly, black patients with prostate cancer were at higher risk for death due to prostate cancer compared

109. eCoach: Development and Pilot Testing of a Decision Aid for Prostate Cancer (pdf file)
     digital.ahrq.gov/sites/default/files/docs/activity/r21hs021797-mohan-annual-summary-2012.pdf
     January 01, 2012 - eCoach: Development and Pilot Testing of a Decision Aid for Prostate Cancer EXPLORATORY AND DEVELOPMENTAL … The use of prostate-specific antibody (PSA) as a screening test has led to earlier diagnosis of prostate … cancers, some of which may never lead to harm. … Because treatment can have harmful side effects, it is critically important to educate prostate cancer … Yet current decision aids for prostate cancer treatment have failed to provide patients with needed

110. Evidence-based Practice Center Systematic Review Protocol: Therapies for Clinically Localized Prostate Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
     November 02, 2019 - prostate cancer have cancer confined to the prostate gland or clinically localized prostate cancer … 1) Baseline PSA 2) Gleason score 3) Tumor index scores (e.g., Cancer of the Prostate Risk Assessment … EAU-ESTRO-SIOG Guidelines on Prostate Cancer. … Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. … of the Prostate Risk Assessment Score CLPC= clinically localized prostate cancer EAU= European Association

111. Evidence-based Practice Center Systematic Review Protocol: Therapies for Clinically Localized Prostate Cancer (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
     November 02, 2019 - prostate cancer have cancer confined to the prostate gland or clinically localized prostate cancer … 1) Baseline PSA 2) Gleason score 3) Tumor index scores (e.g., Cancer of the Prostate Risk Assessment … EAU-ESTRO-SIOG Guidelines on Prostate Cancer. … Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. … of the Prostate Risk Assessment Score CLPC= clinically localized prostate cancer EAU= European Association

112. eCoach: Development and Pilot Testing of a Decision Aid for Prostate Cancer - 2012 | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/ecoach-development-and-pilot-testing-decision-aid-prostate-cancer/annual-summary/2012
     January 01, 2012 - eCoach: Development and Pilot Testing of a Decision Aid for Prostate Cancer - 2012 Project … Name eCoach: Development and Pilot Testing of a Decision Aid for Prostate Cancer Principal … The use of prostate-specific antibody (PSA) as a screening test has led to earlier diagnosis of prostate … cancers, some of which may never lead to harm. … Because treatment can have harmful side effects, it is critically important to educate prostate cancer

113. Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: Research Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-protocol.pdf
     April 17, 2024 - men are affected by prostate cancer disproportionately compared with White men,4 with a prostate cancer … These include reduced access to prostate-specific antigen-based (PSA) screening and high- quality prostate … Prostate cancers vary in rates of progression, with some being very indolent. … in men with low-risk prostate cancer. … Cancer Stat Facts: Prostate Cancer.

114. Brooks_ECCS2012 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/brooks_eccs2012.pdf
     January 01, 2012 - Cancer Screening  Guidelines Durado  Brooks, M.D., M.P.H. … with prostate cancer screening.   … findin prostate  cancer at an earlier stage. • Screening might lower a man’s risk of dying from   … prostate cancer — but this is not entirely  clear. • Screening gives many false-­‐negative  and …  Cancer  Screening  Guidelines for Health Care Professionals issued by  the American Cancer

115. Brooks_ECCS2012 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/brooks_eccs2012.pdf
     January 01, 2012 - Cancer Screening  Guidelines Durado  Brooks, M.D., M.P.H. … with prostate cancer screening.   … findin prostate  cancer at an earlier stage. • Screening might lower a man’s risk of dying from   … prostate cancer — but this is not entirely  clear. • Screening gives many false-­‐negative  and …  Cancer  Screening  Guidelines for Health Care Professionals issued by  the American Cancer

116. Disposition of Comments for PCA3 Testing for the Diagnosis and Management of Prostate Cancer (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_disposition-comments.pdf
     April 01, 2013 - “A recent evidence review found no reduction in prostate cancer-specific mortality based on tPSA screening … Maybe it is enough to simply state that the use and effectiveness of prostate cancer screening with … This may or may not influence the sensitivity and specificity of prostate cancer screening with PSA. … cancer screening. … cancer screening.

117. Public Comment on Draft Recommendation Statements: Screening for Coronary Heart Disease, Hearing Loss, and Prostate Cancer | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-recommendation-statements-screening-coronary-heart-disease-hearing-loss-and-prostate-cancer
     November 30, 2011 - Public Comment on Draft Recommendation Statements: Screening for Coronary Heart Disease, Hearing Loss … , and Prostate Cancer Share to Facebook Share to X Share to WhatsApp … for coronary heart disease, hearing loss, and prostate cancer. … For screening for hearing loss in older adults : comments submitted between October 4 and October 11 … For screening for prostate cancer : comments submitted on October 11, 2011 before the late afternoon

118. Disposition of Comments Report for Multigene Panels in Prostate Cancer Risk Assessment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_disposition-comments.pdf
     July 03, 2012 - Disposition of Comments Report for Multigene Panels in Prostate Cancer Risk Assessment Source: http … Multigene Panels in Prostate Cancer Risk Assessment. … A summary of the genetics of prostate cancer as well as of its heritability would have been welcome, … part of the introduction has been re- organized, to make information on genetics of prostate cancer … We have added a reference to the Vickers paper in JCO to the summary of prostate cancer screening in

119. Sb42
     meps.ahrq.gov/data_files/publications/st42/sb42.xml
     September 01, 2004 - STATISTICAL BRIEF #42 September 2004 Screening for Prostate Cancer with the Prostate-Specific Antigen … cancer screening. … Screening for Prostate Cancer with the Prostate-Specific Antigen Test, United States, 2002. … Screening for prostate cancer with the prostate-specific antigen test, by age, 2002 sb042f1.gif … Screening for prostate cancer with the prostate-specific antigen test, by age, 2002 Source: Center

120. Can screening among the general adult male population for elevated PCA3 (also known as DD3) gene expression, to identify those at risk for prostate cancer who may be candidates for prostate biopsy, reduce morbidity and mortality? | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/can-screening-among-the-general-adult-male-population-for-elevated-pca3-also-known-as-dd3-gene-expression-to-identify-those-at-risk-for-prostate-cancer-who-may-be-candidates-for-prostate-biopsy-reduce-morbidity-and-mortality
     November 01, 2017 - elevated PCA3 (also known as DD3) gene expression, to identify those at risk for prostate cancer who … , to identify those at risk for prostate cancer who may be candidates for prostate biopsy, reduce morbidity … cancer screening tests vs. screening by PSA testing, other screening methods, or no screening. … May lead to unnecessary follow-up for men who are asymptomatic or have slowly progressing prostate cancer … Prostate cancer is among the most frequently diagnosed and deadliest cancers among men in the U.S.